| __timestamp | Dynavax Technologies Corporation | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 152500000 |
| Thursday, January 1, 2015 | 86943000 | 187800000 |
| Friday, January 1, 2016 | 84493000 | 184000000 |
| Sunday, January 1, 2017 | 64988000 | 167700000 |
| Monday, January 1, 2018 | 74951000 | 218600000 |
| Tuesday, January 1, 2019 | 62331000 | 187400000 |
| Wednesday, January 1, 2020 | 28607000 | 177700000 |
| Friday, January 1, 2021 | 32228000 | 122000000 |
| Saturday, January 1, 2022 | 46600000 | 123100000 |
| Sunday, January 1, 2023 | 54886000 | 122500000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Perrigo Company plc and Dynavax Technologies Corporation have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Perrigo consistently outpaced Dynavax, investing nearly 2.5 times more on average. Notably, in 2018, Perrigo's R&D expenses peaked, reaching a staggering 218% of Dynavax's expenditure that year. However, both companies experienced a downward trend in their R&D spending, with Perrigo's investment decreasing by approximately 33% from its peak, while Dynavax saw a 35% reduction from its highest point in 2015. This decline raises questions about future innovation and competitiveness. As the pharmaceutical industry faces new challenges, the strategic allocation of R&D resources will be crucial for these companies to maintain their edge.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Dynavax Technologies Corporation
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation
R&D Insights: How Lantheus Holdings, Inc. and Perrigo Company plc Allocate Funds
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs Perrigo Company plc
Comparing Innovation Spending: TG Therapeutics, Inc. and Dynavax Technologies Corporation
Comparing Innovation Spending: CRISPR Therapeutics AG and Perrigo Company plc
Analyzing R&D Budgets: Perrigo Company plc vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs MorphoSys AG
R&D Spending Showdown: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Perrigo Company plc vs Vericel Corporation
R&D Spending Showdown: Perrigo Company plc vs BioCryst Pharmaceuticals, Inc.